BRD9 blockade could also suppress AR-target gene induction, even in the castration-resistant state, indicating the possibility that BRD9 could serve as a treatment target in therapy-resistant PCa, even though the exact role of BRD9 in PCa progression requires further clarification [22]. This evidence concerns the gene BRD9 and posterior cortical atrophy.